Glucose and methionine uptake by rat brain tumor treated with prodrug- activated gene therapy

Nuclear Medicine and Biology

Volumn 25, Issue 3, 1998, Pages 247-250

  Namba, Hiroki ^a   Iwadate, Yasuo ^a   Iyo, Masaomi ^b   Fukushi, Kiyoshi ^b   Irie, Toshiaki ^b   Sueyoshi, Kanji ^a   Tagawa, Masatoshi ^a   Sakiyama, Shigeru ^a  

^a CHIBA CANCER CENTER   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

Brain tumor; Fluorodeoxyglucose; Gene therapy; Methionine; Thymidine kinase gene; Tumor metabolism

Indexed keywords

ACICLOVIR; FLUORODEOXYGLUCOSE F 18; METHIONINE C 11; PRODRUG; THYMIDINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CANCER; CONTROLLED STUDY; DOSE RESPONSE; DRUG UPTAKE; GENE EXPRESSION; GENE THERAPY; GLIOSARCOMA; HERPES SIMPLEX VIRUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RAT; TUMOR CELL DESTRUCTION; TUMOR VOLUME; VIRUS GENE;

ACYCLOVIR; ANIMALS; ANTIVIRAL AGENTS; BIOLOGICAL TRANSPORT; BRAIN NEOPLASMS; CARBON RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GENE THERAPY; GLIOSARCOMA; GLUCOSE; MALE; METHIONINE; PRODRUGS; RADIOPHARMACEUTICALS; RATS; RATS, INBRED F344; SIMPLEXVIRUS; THYMIDINE KINASE;

EID: 0032054673     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(97)00171-6     Document Type: Article

References (23)

1. 1. Arienti F., Sule-Suso J., Melani C., Maccalli C., Belli F., Illeni M. T., Anichini A., Cascinelli N., Colombo M. P. and Parmiani G. (1994) Interleukin-2 gene-transduced human melanoma cells efficiently stimulate MHC-unrestricted and MHC-restricted autologous lymphocytes. Hum. Gene Ther. 5, 1139-1150.
2. 2. Colombo B. M., Benedetti S., Ottolenghi S., Mora M., Pollo B., Poli G. and Finocchiaro G. (1995) The "bystander effect": Association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Hum. Gene Ther. 6, 763-772.
3. 11C]tyrosine and fluorine-18-fluorodeoxyglucose. J. Nucl. Med. 33, 373-379.
4. 11C]L-methionine uptake in gliomas. Neurosurgery 25, 720-728.
5. 5. De Witte O., Hildebrand J., Luxen A. and Goldman S. (1994) Acute effect of carmustine on glucose metabolism in brain and glioblastoma. Cancer 74, 2836-2842.
6. 18F]fluorodeoxyglucose and positron emission tomography. Neurology 32, 1323-1329.
7. 18F]fluorodeoxyglucose in brain tumors: A powerful diagnostic and prognostic tool. Invest. Radiol. 22, 360-371.
8. 8. Freeman S. M., Abboud C. N., Whartenby K. A., Packman C. H., Koeplin D. S., Moolten F. L. and Abraham G. N. (1993) The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 53, 5274-5283.
9. 9. Hölzer T., Herholz K., Jeske J. and Heiss W.-D. (1993) FDG-PET as a prognostic indicator in radiochemotherapy of glioblastoma. J. Comput. Assist. Tomogr. 17, 681-687.
10. 3H]thymidine, and gallium-67. J. Nucl. Med. 32, 2118-2123.
11. 11. Mineura K., Yasuda T., Kowada M., Ogawa T., Shishido F. and Uemura K. (1987) Positron emission tomographic evaluation of radiochemotherapeutic effect of regional cerebral hemocirculation and metabolism in patients with gliomas. J. Neurooncol. 5, 277-285.
12. 12. Mineura K., Sasajima T., Kowada M., Ogawa T., Hatazawa J., Shishido F. and Uemura K. (1994) Perfusion and metabolism in predicting the survival of patients with cerebral gliomas. Cancer 73, 2386-2394.
13. 13. Moolten F. L. (1986) Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy. Cancer Res. 46, 5276-5281.
14. 14. Moolten F. L. and Wells J. M. (1990) Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J. Natl. Cancer Inst. 82, 297-300.
15. 15. Namba H., Iwadate Y., Tagawa M., Kimura M., Shimizu H., Sato Y., Sueyoshi K. and Sakiyama S. (1996) Evaluation of the bystander effect in experimental brain tumors bearing herpes simplex virus-thymidine kinase gene by serial magnetic resonance imaging. Hum. Gene Ther. 7, 1847-1852.
16. 16. Ogawa T., Shishido F., Kanno I., Inugami A., Fujita H., Murakami M., Shimosegawa E., Ito H., Hatazawa J., Okudera T., Uemura K., Yasui N. and Mineura K. (1993) Cerebral glioma: Evaluation with methionine PET. Radiology 186, 45-53.
17. 17. Oldfield E. H. (1993) Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum. Gene Ther. 4, 39-63.
18. 18. Patronas N. J., Di Chiro G., Kufta C. V., Bairamian D., Kornblith P. L., Simon R. and Larson S. M. (1985) Prediction of survival in glioma patients by means of positron emission tomography. J. Neurosurg. 62, 816-822.
19. 19. Rozental J. M., Levine R. L., Nickles R. J. and Dobkin J. A. (1989) Glucose uptake by glioma after treatment: A positron emission study. Arch. Neurol. 46, 1302-1307.
20. 20. Rozental J. M., Levine R. L., Mehta M. P., Kinsella T. J., Levine A. B., Algan O., Mendoza M., Hanson J. M., Schrader D. A. and Nickles R. J. (1991) Early changes in tumor metabolism after treatment: The effects of stereotactic radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 20, 1053-1060.
21. 21. Samejima Y. and Meruelo D. (1995) 'Bystander killing' induces apoptosis and is inhibited by forskolin. Gene Ther. 2, 50-58.
22. 22. Sato K., Kameyama M., Ishiwata K., Katakura R. and Yoshimoto T. (1992) Metabolic changes of glioma following chemotherapy: An experimental study using four PET tracers. J. Neurooncol. 14, 81-89.
23. 23. Schifter T., Hoffman J. M., Hanson M. W., Boyko O. B., Beam C., Paine S., Schold S. C., Burger P. C. and Coleman R. E. (1993) Serial FDG-PET studies in the prediction of survival in patients with primary brain tumors. J. Comput. Assist. Tomogr. 17, 509-516.